Novel Eph antagonist, inhibiting Eph/ephrin interactions, enhancing glucose-stimulated insulin secretion (GSIS), and acting as a hypoglycemic agent

The first bifunctional (chemoreactive and clickable) probe for Adenosine A1 and A3 Receptors

Potent kynurenine 3-monooxygenase (kynurenine 3-hydroxylase; KMO) inhibitor

Novel superagonist of the urotensin-II (UT) receptor

Novel Potent antagonist of the Urotensin-II (UT) Receptor

Novel superagonist of the urotensin-II (UT) receptor

Novel potent antagonist of the Urotensin-II (UT) receptor

Novel E-Selectin antagonist, disrupting cell survival pathway activation, enhancing chemotherapy response and protecting from toxicity such as mucositis with improved survival in vivo

Novel Neuropeptide Y Y4 Receptor (Y4R) Antagonist (pK i values <7.57)

Novel Potent Neuropeptide Y Y4 Receptor (Y4R) Partial Agonist (pK i : 8.47)

Natural flavonoid from the leaves of Glycyrrhiza uralensis

Novel Red-Emitting Fluorescent Dualsteric Probe for the Muscarinic Acetylcholine M2 Receptor

Novel FAAH inhibitor

Potent, selective, and irreversible inhibitor of fatty acid amide hydrolase (FAAH)

Novel potent partial agonist of histamine H4 receptors (H4R)

Novel potent partial agonist of histamine H4 receptors (H4R)

Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H3 and H4 Receptors, acting as a partial agonist at the hH3R [pEC50 (reporter gene) 8.77] and as an inverse agonist/antagonist at the h/mH4Rs [pIC50 (reporter gene) 8.76/7.08;

Novel subtype selective histamine H2 receptor G protein-biased agonist

Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo

Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo

Novel NPY Y1 Receptor Antagonist

Novel fluorescent histamine H3 receptor ligand